Literature DB >> 23982324

Ketamine for treatment-resistant depression: ready or not for clinical use?

A John Rush.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23982324     DOI： 10.1176/appi.ajp.2013.13081034

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  8 in total

1.  The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression.

Authors:  Kenji Hashimoto
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-04-24       Impact factor: 2.582

Review 2.  Antidepressant actions of ketamine: from molecular mechanisms to clinical practice.

Authors:  Lisa M Monteggia; Carlos Zarate
Journal:  Curr Opin Neurobiol       Date:  2015-01-03       Impact factor: 6.627

3.  A randomized controlled trial of intranasal ketamine in major depressive disorder.

Authors:  Kyle A B Lapidus; Cara F Levitch; Andrew M Perez; Jess W Brallier; Michael K Parides; Laili Soleimani; Adriana Feder; Dan V Iosifescu; Dennis S Charney; James W Murrough
Journal:  Biol Psychiatry       Date:  2014-04-03       Impact factor: 13.382

4.  The role of ketamine in treatment-resistant depression: a systematic review.

Authors:  Gianluca Serafini; Robert H Howland; Fabiana Rovedi; Paolo Girardi; Mario Amore
Journal:  Curr Neuropharmacol       Date:  2014-09       Impact factor: 7.363

5.  Ketamine: stimulating antidepressant treatment?

Authors:  Gin S Malhi; Yulisha Byrow; Frederick Cassidy; Andrea Cipriani; Koen Demyttenaere; Mark A Frye; Michael Gitlin; Sidney H Kennedy; Terence A Ketter; Raymond W Lam; Rupert McShane; Alex J Mitchell; Michael J Ostacher; Sakina J Rizvi; Michael E Thase; Mauricio Tohen
Journal:  BJPsych Open       Date:  2016-05-11

6.  Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans.

Authors:  Suresh D Muthukumaraswamy; Alexander D Shaw; Laura E Jackson; Judith Hall; Rosalyn Moran; Neeraj Saxena
Journal:  J Neurosci       Date:  2015-08-19       Impact factor: 6.167

Review 7.  Glia in the cytokine-mediated onset of depression: fine tuning the immune response.

Authors:  Wendy K Jo; Yuanyuan Zhang; Hinderk M Emrich; Detlef E Dietrich
Journal:  Front Cell Neurosci       Date:  2015-07-10       Impact factor: 5.505

Review 8.  Ketamine, Transcranial Magnetic Stimulation, and Depression Specific Yoga and Mindfulness Based Cognitive Therapy in Management of Treatment Resistant Depression: Review and Some Data on Efficacy.

Authors:  Basant Pradhan; Tapan Parikh; Ramkrishna Makani; Madhusmita Sahoo
Journal:  Depress Res Treat       Date:  2015-10-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.